- Home
- CMMB vs AIRI Comparison
CMMB vs AIRI Comparison
Compare CMMB & AIRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMMB
- AIRI
- Stock Information
- Founded
- CMMB 2004
- AIRI 1979
- Country
- CMMB Israel
- AIRI United States
- Employees
- CMMB N/A
- AIRI N/A
- Industry
- CMMB Biotechnology: Pharmaceutical Preparations
- AIRI Military/Government/Technical
- Sector
- CMMB Health Care
- AIRI Industrials
- Exchange
- CMMB Nasdaq
- AIRI Nasdaq
- Market Cap
- CMMB 13.8M
- AIRI 13.5M
- IPO Year
- CMMB N/A
- AIRI N/A
- Fundamental
- Price
- CMMB $2.54
- AIRI $2.92
- Analyst Decision
- CMMB Strong Buy
- AIRI
- Analyst Count
- CMMB 2
- AIRI 0
- Target Price
- CMMB $26.50
- AIRI N/A
- AVG Volume (30 Days)
- CMMB 80.5K
- AIRI 31.4K
- Earning Date
- CMMB 11-20-2025
- AIRI 11-14-2025
- Dividend Yield
- CMMB N/A
- AIRI N/A
- EPS Growth
- CMMB N/A
- AIRI N/A
- EPS
- CMMB N/A
- AIRI N/A
- Revenue
- CMMB N/A
- AIRI $50,031,000.00
- Revenue This Year
- CMMB N/A
- AIRI N/A
- Revenue Next Year
- CMMB N/A
- AIRI $3.53
- P/E Ratio
- CMMB N/A
- AIRI N/A
- Revenue Growth
- CMMB N/A
- AIRI N/A
- 52 Week Low
- CMMB $2.36
- AIRI $2.77
- 52 Week High
- CMMB $9.84
- AIRI $4.89
- Technical
- Relative Strength Index (RSI)
- CMMB 42.45
- AIRI 45.24
- Support Level
- CMMB $2.36
- AIRI $2.77
- Resistance Level
- CMMB $2.85
- AIRI $2.96
- Average True Range (ATR)
- CMMB 0.20
- AIRI 0.11
- MACD
- CMMB -0.02
- AIRI -0.00
- Stochastic Oscillator
- CMMB 32.71
- AIRI 54.17
About CMMB Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101, treating rare fibrotic conditions.
About AIRI Air Industries Group
Air Industries Group is an aerospace and defense company. Its manufactures and designs structural parts and assemblies that focus on flight safety, including landing gear, arresting gear, engine mounts, flight controls, throttle quadrants, jet engines, and other components. The company also provides sheet metal fabrication of aerostructures, tube bending, and welding services.